Unknown

Dataset Information

0

Targeting VE-PTP activates TIE2 and stabilizes the ocular vasculature.


ABSTRACT: Retinal and choroidal neovascularization (NV) and vascular leakage contribute to visual impairment in several common ocular diseases. The angiopoietin/TIE2 (ANG/TIE2) pathway maintains vascular integrity, and negative regulators of this pathway are potential therapeutic targets for these diseases. Here, we demonstrated that vascular endothelial-protein tyrosine phosphatase (VE-PTP), which negatively regulates TIE2 activation, is upregulated in hypoxic vascular endothelial cells, particularly in retinal NV. Intraocular injection of an anti-VE-PTP antibody previously shown to activate TIE2 suppressed ocular NV. Furthermore, a small-molecule inhibitor of VE-PTP catalytic activity (AKB-9778) activated TIE2, enhanced ANG1-induced TIE2 activation, and stimulated phosphorylation of signaling molecules in the TIE2 pathway, including AKT, eNOS, and ERK. In mouse models of neovascular age-related macular degeneration, AKB-9778 induced phosphorylation of TIE2 and strongly suppressed NV. Ischemia-induced retinal NV, which is relevant to diabetic retinopathy, was accentuated by the induction of ANG2 but inhibited by AKB-9778, even in the presence of high levels of ANG2. AKB-9778 also blocked VEGF-induced leakage from dermal and retinal vessels and prevented exudative retinal detachments in double-transgenic mice with high expression of VEGF in photoreceptors. These data support targeting VE-PTP to stabilize retinal and choroidal blood vessels and suggest that this strategy has potential for patients with a wide variety of retinal and choroidal vascular diseases.

SUBMITTER: Shen J 

PROVIDER: S-EPMC4191011 | biostudies-literature | 2014 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications


Retinal and choroidal neovascularization (NV) and vascular leakage contribute to visual impairment in several common ocular diseases. The angiopoietin/TIE2 (ANG/TIE2) pathway maintains vascular integrity, and negative regulators of this pathway are potential therapeutic targets for these diseases. Here, we demonstrated that vascular endothelial-protein tyrosine phosphatase (VE-PTP), which negatively regulates TIE2 activation, is upregulated in hypoxic vascular endothelial cells, particularly in  ...[more]

Similar Datasets

| S-EPMC6607018 | biostudies-literature
| S-EPMC7735951 | biostudies-literature
| S-EPMC8742526 | biostudies-literature
| S-EPMC4689167 | biostudies-literature
| S-EPMC6504901 | biostudies-other
| S-SCDT-10_15252-EMMM_202216128 | biostudies-other
| S-EPMC8558974 | biostudies-literature
2019-05-04 | PXD010959 | Pride
| S-EPMC4835530 | biostudies-literature
| S-EPMC7025541 | biostudies-literature